The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70
Sawada, M., Hayes, P., & Matsuyama, S. (2003) · Nature Cell Biology · doi:10.1038/ncb955 · Cited by 161
RetractedCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
Drug resistance in cancer: An overview
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014) · Cancers · doi:10.3390/cancers6031769 · Cited by 2,463
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami
Carraway, R., & Leeman, S. E. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43429-7 · Cited by 1,537
Geysen, H. M., Meloen, R. H., & Barteling, S. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.13.3998 · Cited by 1,475
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Organ targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Polyarginine enters cells more efficiently than other polycationic homopolymers
Mitchell, D. J., Steinman, L., Kim, D. T., Fathman, C. G., & Rothbard, J. B. (2000) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.2000.00723.x · Cited by 1,084
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 984
Anastasi, A., Erspamer, V., & Bucci, M. (1971) · Experientia · doi:10.1007/bf02145873 · Cited by 931
Lin, Y.-Z., Yao, S., Veach, R. A., Torgerson, T. R., & Hawiger, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14255 · Cited by 918
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
Heitz, F., Morris, M. C., & Divita, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00057.x · Cited by 867
Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting
Greish, K. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_3 · Cited by 841
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799
The Pharmacology and Clinical Use of Methotrexate
Jolivet, J., Cowan, K. H., Curt, G. A., Clendeninn, N. J., & Chabner, B. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311033091805 · Cited by 786
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Cell penetration by transportan
Pooga, M., Hällbrink, M., Zorko, M., & Langel, U. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.67 · Cited by 679
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
Principles in the design of ligand-targeted cancer therapeutics and imaging agents
Srinivasarao, M., Galliford, C. V., & Low, P. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4519 · Cited by 671
Cell-penetrating peptides: breaking through to the other side
Koren, E., & Torchilin, V. P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.012 · Cited by 670
Cationic TAT peptide transduction domain enters cells by macropinocytosis
Kaplan, I. M., Wadia, J. S., & Dowdy, S. F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.018 · Cited by 668
Mas-Moruno, C., Rechenmacher, F., & Kessler, H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728639 · Cited by 647
Rothbard, J. B., Jessop, T. C., Lewis, R. S., Murray, B. A., & Wender, P. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0482536 · Cited by 624
Plow, E. F., Pierschbacher, M. D., Ruoslahti, E., Marguerie, G. A., & Ginsberg, M. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8057 · Cited by 581
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Mitsudomi, T., & Yatabe, Y. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07448.x · Cited by 559
Jensen, R. T., Battey, J. F., Spindel, E. R., & Benya, R. V. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07108 · Cited by 536
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
Morris, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2730 · Cited by 535
Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides
Drin, G., Cottin, S., Blanc, E., Rees, A. R., & Temsamani, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303938200 · Cited by 530
Varner, J. A., & Cheresh, D. A. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80115-3 · Cited by 522
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
Thundimadathil, J. (2012) · Journal of Amino Acids · doi:10.1155/2012/967347 · Cited by 491
Cell-penetrating peptides: tools for intracellular delivery of therapeutics
Deshayes, S., Morris, M. C., Divita, G., & Heitz, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5109-0 · Cited by 483
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., & Bienert, M. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00161-8 · Cited by 448
Cell-penetrating and cell-targeting peptides in drug delivery
Vivès, E., Schmidt, J., & Pèlegrin, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.03.001 · Cited by 441
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460800 · Cited by 434
Structural and functional characterization of human immunodeficiency virus tat protein
Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., & Rosen, C. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.1-8.1989 · Cited by 429
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Mutt, V., & Said, S. I. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03373.x · Cited by 414
MODLIN, I. M., PAVEL, M., KIDD, M., & GUSTAFSSON, B. I. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04174.x · Cited by 410
PEGylation in anti-cancer therapy: An overview
Mishra, P., Nayak, B., & Dey, R. K. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.08.011 · Cited by 382
Targeted delivery of magnetic aerosol droplets to the lung
Dames, P., Gleich, B., Flemmer, A., Hajek, K., Seidl, N., Wiekhorst, F., Eberbeck, D., Bittmann, I., Bergemann, C., Weyh, T., et al. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.217 · Cited by 382
Nanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 364
Rousselle, C., Clair, P., Lefauconnier, J.-M., Kaczorek, M., Scherrmann, J.-M., & Temsamani, J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26466-x · Cited by 357
Kosuge, M., Takeuchi, T., Nakase, I., Jones, A. T., & Futaki, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700289w · Cited by 356
Ledermann, J. A., Canevari, S., & Thigpen, T. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv250 · Cited by 347
Translocation and Endocytosis for Cell-penetrating Peptide Internalization
Jiao, C.-Y., Delaroche, D., Burlina, F., Alves, I. D., Chassaing, G., & Sagan, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056309 · Cited by 345
Barry, M. A., Dower, W. J., & Johnston, S. A. (1996) · Nature Medicine · doi:10.1038/nm0396-299 · Cited by 338
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
Binetruy-Tournaire, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1525 · Cited by 295
Porkka, K., Laakkonen, P., Hoffman, J. A., Bernasconi, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062189599 · Cited by 291
VE-Cadherin-Derived Cell-Penetrating Peptide, pVEC, with Carrier Functions
Elmquist, A., Lindgren, M., Bartfai, T., & Langel, Ü. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5316 · Cited by 290
Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines
Tünnemann, G., Ter‐Avetisyan, G., Martin, R. M., Stöckl, M., Herrmann, A., & Cardoso, M. C. (2008) · Journal of Peptide Science · doi:10.1002/psc.968 · Cited by 286
From Combinatorial Chemistry to Cancer-Targeting Peptides
Aina, O. H., Liu, R., Sutcliffe, J. L., Marik, J., Pan, C.-X., & Lam, K. S. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700073y · Cited by 285
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Deletion analogues of transportan
Soomets, U., Lindgren, M., Gallet, X., Hällbrink, M., Elmquist, A., Balaspiri, L., Zorko, M., Pooga, M., Brasseur, R., & Langel, Ü. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00216-9 · Cited by 283
Receptor mediated uptake of peptides that bind the human transferrin receptor
Lee, J. H., Engler, J. A., Collawn, J. F., & Moore, B. A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02073.x · Cited by 280
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells
Laakkonen, P., Åkerman, M. E., Biliran, H., Yang, M., Ferrer, F., Karpanen, T., Hoffman, R. M., & Ruoslahti, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403317101 · Cited by 275
Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation
Covic, L., Misra, M., Badar, J., Singh, C., & Kuliopulos, A. (2002) · Nature Medicine · doi:10.1038/nm760 · Cited by 275
Steps in tumor metastasis: new concepts from intravital videomicroscopy
Chambers, A. F., MacDonald, I. C., Schmidt, E. E., Koop, S., Morris, V. L., Khokha, R., & Groom, A. C. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690599 · Cited by 265
Chen, X., Plasencia, C., Hou, Y., & Neamati, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049165z · Cited by 256
Dubikovskaya, E. A., Thorne, S. H., Pillow, T. H., Contag, C. H., & Wender, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805374105 · Cited by 249
Arginine-rich peptides and their internalization mechanisms
Futaki, S., Nakase, I., Tadokoro, A., Takeuchi, T., & Jones, A. T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350784 · Cited by 246
Integrin Targeted Delivery of Chemotherapeutics
Chen, K., & Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0189 · Cited by 242
A gastrin releasing peptide from the porcine nonantral gastric tissue.
McDonald, T. J., Nilsson, G., Vagne, M., Ghatei, M., Bloom, S. R., & Mutt, V (1978) · Gut · doi:10.1136/gut.19.9.767 · Cited by 239
Distribution of somatostatin receptors in normal and tumor tissue
Reubi, J. C., Kvols, L., Krenning, E., & Lamberts, S. W. J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90217-z · Cited by 234
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.5.1189 · Cited by 234
Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Perche, F., & Torchilin, V. P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/705265 · Cited by 230
Anticancer drug development: the grand challenges
Hait, W. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3144 · Cited by 230
Zhang, D., Wang, J., & Xu, D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.020 · Cited by 227
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
Hoffman, J. A., Giraudo, E., Singh, M., Zhang, L., Inoue, M., Porkka, K., Hanahan, D., & Ruoslahti, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00273-3 · Cited by 224
TRAIL-coated leukocytes that kill cancer cells in the circulation
Mitchell, M. J., Wayne, E., Rana, K., Schaffer, C. B., & King, M. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316312111 · Cited by 213
Kobayashi, S., Takeshima, K., Park, C. B., Kim, S. C., & Matsuzaki, K. (2000) · Biochemistry · doi:10.1021/bi0004549 · Cited by 213
Tumor microenvironment and angiogenesis
Nyberg, P. (2008) · Frontiers in Bioscience · doi:10.2741/3173 · Cited by 212
Burgus, R., Ling, N., Butcher, M., & Guillemin, R. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.684 · Cited by 212
Lindgren, M., Rosenthal-Aizman, K., Saar, K., Eiríksdóttir, E., Jiang, Y., Sassian, M., Östlund, P., Hällbrink, M., & Langel, Ü. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.048 · Cited by 207
Reardon, D. A., Nabors, L. B., Stupp, R., & Mikkelsen, T. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.8.1225 · Cited by 206
Fekete, M., Wittliff, J. L., & Schally, A. V. (1989) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860030302 · Cited by 200
Vives, E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.032 · Cited by 196
Emons, G., Ortmann, O., Becker, M., et al. (1993) · PubMed · Cited by 195
Essler, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251687998 · Cited by 193
The RGD story: a personal account
Ruoslahti, E. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00083-0 · Cited by 189
Handbook of Cell-Penetrating Peptides
(2006) · CRC Press eBooks · doi:10.1201/9781420006087 · Cited by 185
Noncationic Peptides Obtained From Azurin Preferentially Enter Cancer Cells
Taylor, B. N., Mehta, R. R., Yamada, T., Lekmine, F., Christov, K., Chakrabarty, A. M., Green, A., Bratescu, L., Shilkaitis, A., Beattie, C. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2932 · Cited by 184
Drug Targeting Strategies in Cancer Treatment: An Overview
L. Arias, J. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711793564024 · Cited by 176
Structural requirements for cellular uptake of α-helical amphipathic peptides
Scheller, A., Oehlke, J., Wiesner, B., Dathe, M., Krause, E., Beyermann, M., Melzig, M., & Bienert, M. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199904)5:4<185::aid-psc184>3.0.co;2-9 · Cited by 174
A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria
Badosa, E., Ferre, R., Planas, M., Feliu, L., Besalú, E., Cabrefiga, J., Bardají, E., & Montesinos, E. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.010 · Cited by 173
A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids
El-Andaloussi, S., Johansson, H. J., Holm, T., & Langel, Ü. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300255 · Cited by 170
Fernández‐Carneado, J., Kogan, M. J., Castel, S., & Giralt, E. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200352540 · Cited by 170
Nakase, I., Konishi, Y., Ueda, M., Saji, H., & Futaki, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.016 · Cited by 168
NG2 proteoglycan-binding peptides target tumor neovasculature.
Burg, M. A., Pasqualini, R., Arap, W., Ruoslahti, E. I., & Stallcup, W. B. (1999) · PubMed · Cited by 166
Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide
Rhee, M., & Davis, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509813200 · Cited by 164
HALMOS, G., ARENCIBIA, J. M., SCHALLY, A. V., DAVIS, R., & BOSTWICK, D. G. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67947-5 · Cited by 163
Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems
Kondo, E., Saito, K., Tashiro, Y., Kamide, K., Uno, S., Furuya, T., Mashita, M., Nakajima, K., Tsumuraya, T., Kobayashi, N., et al. (2012) · Nature Communications · doi:10.1038/ncomms1952 · Cited by 162
Tumor-activated Prodrugs—A New Approach to Cancer Therapy
Denny, W. A. (2004) · Cancer Investigation · doi:10.1081/cnv-200027148 · Cited by 162
Self-citationMelanocyte-Stimulating Hormone and Adrenocorticotrophic Hormone: Their Relation to Pigmentation
Lerner, A. B., & McGuire, J. S. (1964) · New England Journal of Medicine · doi:10.1056/nejm196403122701101 · Cited by 160
Genetic engineering of proteins with cell membrane permeability
Rojas, M., Donahue, J. P., Tan, Z., & Lin, Y.-Z. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-370 · Cited by 159
pH-sensitive drug-delivery Systems for Tumor Targeting
He, X., Li, J., An, S., & Jiang, C. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.120 · Cited by 159
Micro-PET Imaging of αvβ3-Integrin Expression with 18F-Labeled Dimeric RGD Peptide
Chen, X., Tohme, M., Park, R., Hou, Y., Bading, J. R., & Conti, P. S. (2004) · Molecular Imaging · doi:10.1162/1535350041464892 · Cited by 159
Rousselle, C., Smirnova, M., Clair, P., Lefauconnier, J.-M., Chavanieu, A., Calas, B., Scherrmann, J.-M., & Temsamani, J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29672-5 · Cited by 159
Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
Shadidi, M., & Sioud, M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0280fje · Cited by 156
Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies
Regberg, J., Srimanee, A., & Langel, Ü. (2012) · Pharmaceuticals · doi:10.3390/ph5090991 · Cited by 155
The use of cell-penetrating peptides for drug delivery
Temsamani, J., & Vidal, P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03279-9 · Cited by 153
TumorHoPe: A Database of Tumor Homing Peptides
Kapoor, P., Singh, H., Gautam, A., Chaudhary, K., Kumar, R., & Raghava, G. P. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035187 · Cited by 153
Peptide‐mediated targeted drug delivery
Majumdar, S., & Siahaan, T. J. (2010) · Medicinal Research Reviews · doi:10.1002/med.20225 · Cited by 152
Peng, Z., & Kopec̆ek, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00922 · Cited by 151
Brown, K. C. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790963788 · Cited by 146
Tumor Microenvironment and Angiogenesis
Davis, D. W., Herbst, R. S., & Abbruzzese, J. L. (2007) · CRC Press eBooks · doi:10.1201/9781420004298-10 · Cited by 145
Fukuda, M., Οhyama, C., Lowitz, K., Matsuo, O., Pasqualini, R., Ruoslahti, E. I., & Fukuda, M. (2000) · PubMed · Cited by 144
de Coupade, C., Fittipaldi, A., Chagnas, V., Michel, M., Carlier, S., Tasciotti, E., Darmon, A., Ravel, D., Kearsey, J., Giacca, M., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050401 · Cited by 139
Design of a Tumor-Homing Cell-Penetrating Peptide
Myrberg, H., Zhang, L., Mäe, M. A., & Langel, Ü. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0701139 · Cited by 137
In Vivo Phage Display Selection Yields Atherosclerotic Plaque Targeted Peptides for Imaging
Kelly, K. A., Nahrendorf, M., Yu, A. M., Reynolds, F., & Weissleder, R. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0043-6 · Cited by 136
A non-covalent peptide-based carrier for in vivo delivery of DNA mimics
Morris, M. C., Gros, E., Aldrian, G., Choob, M. V., Archdeacon, J., Heitz, F., & Divita, G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm053 · Cited by 129
Hölig, P., Bach, M., Völkel, T., Nahde, T., Hoffmann, S., Müller, R., & Kontermann, R. E. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh055 · Cited by 129
Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements
Koren, E., Apte, A., Sawant, R. R., Grunwald, J., & Torchilin, V. P. (2011) · Drug Delivery · doi:10.3109/10717544.2011.567310 · Cited by 127
Qi, X., Shi, Gao, Q., & Xiang, ■. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30104 · Cited by 125
Fajloun, Z., Kharrat, R., Chen, L., Lecomte-Pradines, C., di Luccio, E., Bichet, D., Ayeb, M. E., Rochat, H., Allen, P. D., Pessah, I. N., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01239-4 · Cited by 124
Somatostatin Receptor-Targeted Anti-Cancer Therapy
Sun, L., & Coy, D. H. (2010) · Current Drug Delivery · doi:10.2174/156720111793663633 · Cited by 123
Characterization of a Novel Cytotoxic Cell‐penetrating Peptide Derived From p14ARF Protein
Johansson, H. J., Andaloussi, S. E., Holm, T., Mäe, M. A., Jänes, J., Maimets, T., & Langel, Ü. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300346 · Cited by 119
He, H., Ye, J., Liu, E., Liang, Q., Liu, Q., & Yang, V. C.-M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.056 · Cited by 119
Duchardt, F., Ruttekolk, I. R., Verdurmen, W. P. R., Lortat‐Jacob, H., Bürck, J., Hufnagel, H., Fischer, R., van den Heuvel, M., Löwik, D. W. P. M., Vuister, G. W., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036426 · Cited by 119
Wang, Z., Yu, Y., Dai, W., Lu, J., Cui, J., Wu, H., Yuan, L., Zhang, H., Wang, X., Wang, J., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.031 · Cited by 116
TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis
Yang, W., Luo, D., Wang, S., Wang, R., Chen, R., Liu, Y., Zhu, T., Ma, X., Liu, R., Xu, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0233 · Cited by 115
Tumor angiogenesis and the role of vascular cell integrin alphavbeta3.
Varner, J. A., & Cheresh, D. A. (1996) · PubMed · Cited by 115
Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy
Wu, Z., Martinez-Fong, D., Trédaniel, J., & Forgez, P. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00184 · Cited by 113
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J. J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie · doi:10.1002/ange.200460800 · Cited by 112
Integrins as signaling molecules and targets for tumor therapy
Ruoslahti, E. (1997) · Kidney International · doi:10.1038/ki.1997.193 · Cited by 111
Cellular Uptake and Cytotoxicity of Drug–Peptide Conjugates Regulated by Conjugation Site
Zhang, P., Cheetham, A. G., Lock, L. L., & Cui, H. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300585h · Cited by 107
Irmer, G., Bürger, C., Müller, R., Ortmann, O., Peter, U., Kakar, S. S., Neill, J. D., Schulz, K. ‐., & Emons, G. (1995) · PubMed · Cited by 106
Brugidou, J., Legrand, C., Méry, J., & Rabié, A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2340 · Cited by 106
N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis
Magzoub, M. M., Sandgren, S., Lundberg, P., Oglęcka, K., Lilja, J., Wittrup, A., Eriksson, L. E. G., Langel, Ü., Belting, M., & Gräslund, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.065 · Cited by 105
Peptides as Carrier for Tumor Diagnosis and Treatment
Langer, M., & Beck‐Sickinger, A. G. (2001) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011013354877 · Cited by 104
A cell-penetrating peptide from a novel pVII–pIX phage-displayed random peptide library
Gao, C., Mao, S., Ditzel, H. J., Farnaes, L., Wirsching, P., Lerner, R. A., & Janda, K. D. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00340-1 · Cited by 103
Tumor Homing Peptides as Molecular Probes for Cancer Therapeutics, Diagnostics and Theranostics
Gautam, A., Kapoor, P., Chaudhary, K., Kumar, R., Open Drug Discovery Consortium, & Raghava, G. P. S. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140217122100 · Cited by 103
Protamine as an Efficient Membrane-Translocating Peptide
Reynolds, F., Weissleder, R., & Josephson, L. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501451 · Cited by 100
Drug delivery and release systems for targeted tumor therapy
Böhme, D., & Beck‐Sickinger, A. G. (2015) · Journal of Peptide Science · doi:10.1002/psc.2753 · Cited by 99
Hong, H.-Y., Lee, H. Y., Kwak, W., Yoo, J., Na, M., So, I. S., Kwon, T., Park, H., Huh, S., Oh, G. T., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00189.x · Cited by 96
Reubi, J. C., Schaer, J., Markwalder, R. V., Waser, B., Horisberger, U., & Laissue, J. A. (1999) · PubMed · Cited by 95
A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery
Zhong, J., Li, L., Zhu, X. D., Guan, S., Yang, Q., Zhou, Z., Zhang, Z., & Huang, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.042 · Cited by 94
Extensive cellular uptake into endothelial cells of an amphipathic β‐sheet forming peptide
Oehlke, J., Krause, E., Wiesner, B., Beyermann, M., & Bienert, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01123-x · Cited by 93
Balayssac, S., Burlina, F., Convert, O., Bolbach, G., Chassaing, G., & Lequin, O. (2006) · Biochemistry · doi:10.1021/bi0518390 · Cited by 93
E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells
Mitchell, M. J., Chen, C. S., Ponmudi, V., Hughes, A. D., & King, M. R. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.018 · Cited by 87
Aroui, S., Ram, N., Appaix, F., Ronjat, M., Kénani, A., Pirollet, F., & WAARD, M. M. D. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9782-1 · Cited by 82
Biswas, S., Dodwadkar, N. S., Deshpande, P. P., Parab, S., & Torchilin, V. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.12.021 · Cited by 81
Massaguer, A., González-Cantó, A., Escribano, E., Barrabés, S., Artigas, G., Moreno, V., & Marchán, V. (2014) · Dalton Transactions · doi:10.1039/c4dt02710h · Cited by 79
Design, Synthesis and Characterization of a New Anionic Cell‐Penetrating Peptide: SAP(E)
Martín, I., Teixidò, M., & Giralt, E. (2011) · ChemBioChem · doi:10.1002/cbic.201000679 · Cited by 79
Opioid agonist and antagonist bivalent ligands as receptor probes
Portoghese, P. S., Ronsisvalle, G., Larson, D. L., Yim, C. B., Sayre, L. M., & Takemori, A. E. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90362-9 · Cited by 79
Colombo, R., Mingozzi, M., Belvisi, L., Arosio, D., Piarulli, U., Carenini, N., Perego, P., Zaffaroni, N., Cesare, M. D., Castiglioni, V., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301058f · Cited by 75
Goodchild, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-188-8_1 · Cited by 75
Mäger, I., Eiríksdóttir, E., Langel, K., Andaloussi, S. E., & Langel, Ü. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.11.001 · Cited by 73
Cashman, S. M., Sadowski, S. L., Morris, D. J., Frederick, J. M., & Kumar‐Singh, R. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0806 · Cited by 71
Riviere, K., Huang, Z. R., Jerger, K., Macaraeg, N., & Szoka, F. C. (2010) · Journal of drug targeting · doi:10.3109/10611861003733953 · Cited by 68
Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
Hyvönen, M. L. K., Enbäck, J., Huhtala, T., Lammi, J., Sihto, H. J., Weisell, J., Joensuu, H., Rosenthal-Aizman, K., Andaloussi, S. E., Langel, Ü., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0684 · Cited by 68
Design of a Tumor Homing Cell-Penetrating Peptide for Drug Delivery
Mäe, M. A., Myrberg, H., Andaloussi, S. E., & Langel, Ü. (2008) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-008-9156-x · Cited by 66
Moktan, S., Perkins, E., Kratz, F., & Raucher, D. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0998 · Cited by 66
Tréhin, R., Krauss, U., Beck‐Sickinger, A. G., Merkle, H. P., & Nielsen, H. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033013.45204.c3 · Cited by 65
Aroui, S., Brahim, S., Hamelin, J., WAARD, M. M. D., Bréard, J., & Kénani, A. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0397-8 · Cited by 64
Han, K., Jeon, M.-J., Kim, K.-A., Park, J., & Choi, S.-Y. (2000) · Molecules and Cells · doi:10.1007/s10059-000-0728-7 · Cited by 62
Tian, R., Wang, H., Niu, R., & Ding, D. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2015.04.028 · Cited by 61
Handl, H. L., Sankaranarayanan, R., Josan, J. S., Vágner, J., Mash, E. A., Gillies, R. J., & Hruby, V. J. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603642 · Cited by 60
Peoples, G. E., Anderson, B. W., Lee, T. V., Murray, J. L., Kudelka, A. P., Wharton, J. T., & Ioannides, C. G. (1999) · PubMed · Cited by 59
Enhanced Cellular Entry and Efficacy of Tat Conjugates by Rational Design of the Auxiliary Segment
Zhang, P., Lock, L. L., Cheetham, A. G., & Cui, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400619v · Cited by 59
Zhang, B., Zhang, Y., Wang, J., Zhang, Y., Chen, J., Pan, Y., Ren, L., Hu, Z., Zhao, J., Liao, M., et al. (2007) · Molecular Medicine · doi:10.2119/2006-00115.zhang · Cited by 56
Song, Q., Chuan, X., Chen, B., He, B., Zhang, H., Dai, W., Wang, X., & Zhang, Q. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1028601 · Cited by 55
Brown, C. K., Modzelewski, R. A., Johnson, C. S., & Wong, M. K. K. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0743-0 · Cited by 52
Aroui, S., Dardevet, L., Ajmia, W. B., de Boisvilliers, M., Perrin, F., Laajimi, A., Boumendjel, A., Kénani, A., Jm, M., & WAARD, M. M. D. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00531 · Cited by 52
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
Kersemans, V., & Cornelissen, B. T. (2010) · Pharmaceuticals · doi:10.3390/ph3030600 · Cited by 51
Does cilengitide deserve another chance?
Tucci, M., Stucci, L. S., & Silvestris, F. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70462-0 · Cited by 49
Transferrin receptors in human cancerous tissues.
Niitsu, Y., Kohgo, Y., Nishisato, T., et al. (1987) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.153.239 · Cited by 48
Peptide-Based Glioma-Targeted Drug Delivery Vector gHoPe2
Eriste, E., Kurrikoff, K., Suhorutšenko, J., Oskolkov, N., Copolovici, D. M., Jones, S., Laakkonen, P. M., Howl, J., & Langel, Ü. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300370w · Cited by 47
Soler, M., Feliu, L., Planas, M., Ribas, X., & Costas, M. (2016) · Dalton Transactions · doi:10.1039/c5dt04529k · Cited by 46
Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors
Pokuri, V. K., Fong, M. K., & Iyer, R. V. (2016) · Current Oncology Reports · doi:10.1007/s11912-015-0492-7 · Cited by 44
Peptide Transport and Delivery into the Central Nervous System
(2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8049-7 · Cited by 43
Ram, N., Weiss, N., Texier, I., Aroui, S., Andreotti, N., Pirollet, F., Ronjat, M., Sabatier, J., Darbon, H., Jacquemond, V., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804727200 · Cited by 39
Soler, M., González‐Bártulos, M., Soriano‐Castell, D., Ribas, X., Costas, M., Tebar, F., Massaguer, A., Feliu, L., & Planas, M. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42422g · Cited by 34
Hurdles in anticancer drug development from a regulatory perspective
Jönsson, B., & Bergh, J. C. S. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.14 · Cited by 33
Mano, M., Henriques, A., Paiva, A. A., PRIETO, M. J. E., Gavilanes, F., Simões, S., & de Lima, M. C. P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.01.014 · Cited by 33
Chung, S. W., Lee, B. S., Choi, J. U., Kim, S. W., Kim, I.-S., Kim, S. Y., & Byun, Y. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00420 · Cited by 30
Cell Penetration Properties of a Highly Efficient Mini Maurocalcine Peptide
Tisseyre, C., Bahembera, E., Dardevet, L., Sabatier, J., Ronjat, M., & WAARD, M. M. D. (2013) · Pharmaceuticals · doi:10.3390/ph6030320 · Cited by 25
Somatostatin Receptor–Mediated Specific Delivery of Paclitaxel Prodrugs for Efficient Cancer Therapy
Huo, M., Zhu, Q., Wu, Q., Yin, T., Wang, L., Yin, L., & Zhou, J. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24438 · Cited by 23
Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16
Soler, M., González‐Bártulos, M., Figueras, E., Ribas, X., Costas, M., Massaguer, A., Planas, M., & Feliu, L. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01875c · Cited by 21
Does cilengitide deserve another chance?–Authors' reply
Stupp, R., Picard, M. A., & Weller, M. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71121-0 · Cited by 20
Miklán, Z., Orbán, E., Bánóczi, Z., & Hudecz, F. (2011) · Journal of Peptide Science · doi:10.1002/psc.1407 · Cited by 17
Cited by
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Riaz, M., Riaz, M., Zhang, X., Lin, C., Wong, K., Chen, X., Zhang, G., Lu, A., & Yang, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010195 · Cited by 509
Molecular photoswitches in aqueous environments
Volarić, J., Szymanski, W., Simeth, N. A., & Feringa, B. L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00547a · Cited by 438
Ramasamy, T., Ruttala, H. B., Gupta, B., Poudel, B. K., Choi, H.-G., Yong, C. S., & Kim, J. O. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.043 · Cited by 373
Electrospun polymer micro/nanofibers as pharmaceutical repositories for healthcare
Feng, X., Li, J., Zhang, X., Liu, T., Ding, J., & Chen, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.020 · Cited by 322
Rational Design of Nanocarriers for Intracellular Protein Delivery
Qin, X., Yu, C., Wei, J., Li, L., Zhang, C., Wu, Q., Liu, J., Yao, S. Q., & Huang, W. (2019) · Advanced Materials · doi:10.1002/adma.201902791 · Cited by 280
Metadata
- Authors
- Dissanayake, S., Denny, W. A., Gamage, S., & Sarojini, V.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 250
- Pages
- 62-76
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2583257650
- Cited by
- 280
- References
- 198
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.